Priming with a DNA vaccine and boosting with an inactivated vaccine enhance the immune response against infectious bronchitis virus

Journal of Virological Methods

Volumn 167, Issue 1, 2010, Pages 84-89

  Guo, Zicheng ^a   Wang, Hongning ^a   Yang, Tai ^a   Wang, Xue ^a   Lu, Dan ^a   Li, Yulin ^a   Zhang, Yi ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

DNA vaccine; Infectious bronchitis virus (IBV); Prime boost

Indexed keywords

DNA VACCINE; IMMUNOGLOBULIN G ANTIBODY; INACTIVATED AVIAN INFECTIOUS BRONCHITIS VIRUS VACCINE; INACTIVATED VIRUS VACCINE; NEUTRALIZING ANTIBODY; NUCLEOCAPSID PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ARTICLE; AVIAN INFECTIOUS BRONCHITIS; AVIAN INFECTIOUS BRONCHITIS VIRUS; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL STRAIN COS7; CELLULAR IMMUNITY; CHICKEN; CONTROLLED STUDY; DRUG EFFICACY; HUMORAL IMMUNITY; IMMUNE RESPONSE; IN VIVO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTECTION; VACCINATION; VIRUS STRAIN;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHICKENS; CORONAVIRUS INFECTIONS; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN G; INFECTIOUS BRONCHITIS VIRUS; INJECTIONS, INTRAMUSCULAR; POULTRY DISEASES; VACCINATION; VACCINES, DNA; VACCINES, INACTIVATED; VIRAL VACCINES;

AVIAN INFECTIOUS BRONCHITIS VIRUS; GALLUS GALLUS;

EID: 77953026995     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2010.03.016     Document Type: Article

References (40)

1. Ariane R., Ratna M., Dennis T., Gert G., Jerome C., Maria G.P., Jaco K., Sampa S., Harikrishnan B., Norman L.L., Jaap G., Katarina R. Evaluation of a prime-boost vaccine schedule with distinct adenovirus vectors against malaria in rhesus monkeys. Vaccine 2009, 27:6226-6233.
2. Bijlenga G., Cook J.K.A., Gelb J., Dewit J.J. Development and use of the H strain of avian infectious bronchitis virus from The Netherlands as a vaccine: a review. Avian Pathol. 2004, 33:550-557.
3. Boots A.M.H., Kusters J.G., Van N.J.M., Zwaagstra K.A., Rijke E., Hensen E.J., Van B.A.M.D.Z. Localization of a T-cell epitope within the nucleocapsid protein of avian coronavirus. Immunology 1991, 74:8-13.
4. Boots A.M.H., Benaissa-Trouw B.J., Hesselink W., Rijke E., Schrier C., Hensen E.J. Induction of anti-viral immune responses by immunization with recombinant-DNA encoded avian coronavirus nucleocapsid protein. Vaccine 1992, 10:119-124.
5. Bot A., Antohi S., Bona C. Immune response of neonates elicited by somatic transgene vaccination with naked DNA. Front Biosci. 1997, 2:173-188.
6. Boyle J.S., Silva A., Brady J.L. DNA immunization: induction of higher avidity antibody and effect of route on T cell cytotoxicity. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:14626-14631.
7. Cavanagh D., Davis P.J., Cook J.K.A., Li D., Kant A., Koch G. Location of the amino acid differences in the S1 spike glycoprotein subunit of closely related serotypes of infectious bronchitis virus. Avian Pathol. 1992, 21:33-43.
8. Cavanagh D., Naqi S. Infectious bronchitis. Diseases of Poultry 1997, 511-526. London. tenth ed. B.W. Calnek, H.J. Barnes, L.R. McDougald, Y.M. Saif (Eds.).
9. Cavanagh D. Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus. Avian Pathol. 2003, 32:567-582.
10. Cavanagh D. Coronavirus avian infectious bronchitis virus. Vet. Res. 2007, 38:281-297.
11. Collisson E.W., Pei J., Dzielaw J., Seo S.H. Cytotoxic T lymphocytes are critical in the control of infectious bronchitis virus in poultry. Dev. Comp. Immunol. 2000, 24:187-200.
12. Fang M., Luis J.S. Antibodies and CD8+ T cells are complementary and essential for natural resistance to a highly lethal cytopathic virus. J. Immunol. 2005, 175:6829-6836.
13. Gonzalez F.A., Milstein C. Low antigen dose favours selection of somatic mutants with hallmarks of antibody affinity maturation. Immunology 1998, 93:149-153.
14. Gregoriadis G., Saffie R., Hart S.L. High yield incorporation of plasmid DNA within liposome: effect on DNA integrity and transfect ion efficiency. J. Drug Target. 1996, 3:469-475.
15. Gregoriadis G., Cormack M.B., Obrenovic M., Perrie Y. Entrapment of plasmid DNA vaccines into liposome by dehydration/rehydration. Methods in molecular medicine, DNA vaccines: methods and protocols 1999, Humana Press Inc., Totowa (NJ), pp. 305-312.
16. Larsen D.L., Karasin A., Olsen C.W. Immunization of pigs against influenza virus infection by DNA vaccine priming followed by killed-virus vaccine boosting. Vaccine 2001, 19:2842-2853.
17. Letellier C., Boxus M., Rosar L., Toussaint J.F., Walravens K., Roels S., Meyer M., Letesson J.J., Kerkhofs P. Vaccination of calves using the BRSV nucleocapsid protein in a DNA prime-protein boost strategy stimulates cell-mediated immunity and protects the lungs against BRSV replication and pathology. Vaccine 2008, 26:4840-4848.
18. Li Y., Stirling C.M.A., Denyer M.S., Hamblin P., Hutchings G., Takamatsu H.H., Barnett P.V. Dramatic improvement in FMD DNA vaccine efficacy and cross-serotype antibody induction in pigs following a protein boost. Vaccine 2008, 26:2647-2656.
19. Ming K.H., Ching C.W., Tsang L.L. Priming with DNA vaccine and boosting with killed vaccine conferring protection of chickens against infectious bursal disease. Vaccine 2007, 25:5417-5427.
20. Morello C.S., Ye M., Spector D.H. Development of a vaccine against murine cytomegalovirus (MCMV), consisting of plasmid DNA and formalin-inactivated MCMV, that provides long-term, complete protection against viral replication. J. Virol. 2002, 76:4822-4835.
21. Peng B., Chen H., Tan Y. Identification of one peptide which inhibited infectivity of avian infectious bronchitis virus in vitro. Sci. China C: Life Sci. 2006, 49:158-163.
22. Pertmer T.M., Robert T.R., Haynes J.R. Influenza virus nucleoprotein-specific immunoglobulin G and cytokine response elicited by DNA vaccination are dependent on the route of vector DNA delivery. J. Virol. 1996, 70:6119-6125.
23. Ramshaw I.A., Ramsay A.J. The prime-boost strategy: exciting prospects for improved vaccination. Immunol. Today 2000, 21:163-165.
24. Reed L., Muench H. A simple method for estimating fifty percent endpoints. Am. J. Hyg. 1938, 27:493-497.
25. Seah J.N., Yu L., Wang J.K. Localization of linear B-cell epitopes on infectious bronchitis virus nucleocapsid protein. Vet. Microbiol. 2000, 75:11-16.
26. Seo S.H., Collisson E.W. Specific cytotoxic T lymphocytes are involved in in vivo clearance of infectious bronchitis virus. J. Virol. 1997, 71:5173-5177.
27. Seo S.H., Wang L., Smith R., Collision E.W. The carboxyl-terminal 120-residue polypeptide of infectious bronchitis virus nucleocapsid induces cytotoxic T lymphocytes and protects chickens from acute infection. J. Virol. 1997, 71:7889-7894.
28. Spaan W., Cavanagh D., Horzinek M.C. Coronaviruses: structure and genome expression. J. Gen. Virol. 1988, 69:2939-2952.
29. Stern D.F., Sefton B.M. Coronavirus proteins: biogenesis of avian coronavirus bronchitis virus. J. Virol. 1982, 44:794-803.
30. Tang M.J., Wang H.N., Zhou S., Tian G.B. Enhancement of the immunogenicity of an infectious bronchitis virus DNA vaccine by a bicistronic plasmid encoding nucleocapsid protein and interleukin-2. J. Virol. Met. 2008, 149:42-48.
31. Tian L., Wang H.N., Lu D., Zhang Y.F., Wang T., Kang R.M. The immunoreactivity of a chimeric multi-epitope DNA vaccine against IBV in chickens. Biochem. Biophys. Res. Commun. 2008, 377:221-225.
32. Wang S.X., Parker C., Taaffe J., Alicia S., Adolfo G.S., Lu S. Heterologous HA DNA vaccine prime-inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses. Vaccine 2008, 26:3626-3633.
33. Wareing M.D., Tannock G.A. Live attenuated vaccines against influenza; an historical review. Vaccine 2001, 19:3320-3330.
34. Whalen B.J., Tony H.P., Parker D.C. Characterization of the effector mechanism of help for antigen-presenting and bystander resting B cell growth mediated by Ia-restricted Th2 helper T cell lines. J. Immunol. 1988, 141:2230-2239.
35. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A. Direct gene transfer into mouse muscle in vivo. Science 1990, 247:1465-1468.
36. Woodland D.L. Jump-starting the immune system: prime-boosting comes of age. Trends Immunol. 2004, 25:98-104.
37. Xie Z.H., Shi X.J., Cai G.P. Preparation of high purified plasmid DNA for mammal cell transfection. Lett. Biotechnol. 2007, 18:803-805.
38. Yang Z.Y., Kong W.P., Huang Y. A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature 2004, 428:561-564.
39. Yin Z., Liu J. Animal Virology 1997, Science Press, Beijing. second ed.
40. Yu L., Liu W., Schnitzlein W.M., Tripathy D.N., Kwang J. Study of protection by recombinant fowl poxvirus expressing C-terminal nucleocapsid protein of infectious bronchitis virus against challenge. Avian Dis. 2001, 45:340-348.